1-18 of 18
Daniel A. Haber
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A017: High-throughput microfluidic enrichment of circulating tumor cells from entire diagnostic leukapheresis for comprehensive liquid biopsy

Avanish Mishra, Shih-Bo Huang, Taronish Dubash, Risa Burr, Jon F. Edd, Ben S. Wittner, Quinn E. Cunneely, Victor R. Putaturo, Akansha Deshpande, Ezgi Antmen, Kaustav A. Gopinathan, Keisuke Otani, Yoshiyuki Miyazawa, Ji Eun Kwak, Sara Y. Guay, Justin P. Kelly, John Walsh, Linda T. Nieman, Isabella Galler, PuiYee Chan, Michael S. Lawrence, Ryan J. Sullivan, Aditya Bardia, Douglas S. Micalizzi, Lecia V. Sequist, Richard J. Lee, Joseph W. Franses, David T. Ting, Patricia A. R. Brunker, Shyamala Maheswaran, David T. Miyamoto, Daniel A. Haber, Mehmet Toner
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (21_Supplement): A017.
https://doi.org/10.1158/1557-3265.LIQBIOP24-A017
Published: 13 November 2024
View article titled, Abstract A017: High-throughput microfluidic enrichment of circulating tumor cells from entire diagnostic leukapheresis for comprehensive liquid biopsy
Journal Articles

Abstract IA005: Tumor cell-based liquid biopsy to characterize prostate cancer

Daniel A Haber, Shyamala Maheswaran, Hongshan Guo, Joanna Vuille, Shih-Bo Huang, Ben S Wittner, Lecia V Sequist, Richard J Lee, Patricia AR Brunker, David T Miyamoto, Avanish Mishra, Mehmet Toner
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (21_Supplement): IA005.
https://doi.org/10.1158/1557-3265.LIQBIOP24-IA005
Published: 13 November 2024
View article titled, Abstract IA005: Tumor cell-based liquid biopsy to characterize prostate cancer
Journal Articles

Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer

Neelima Vidula, Taronish Dubash, Michael S. Lawrence, Antoine Simoneau, Andrzej Niemierko, Erica Blouch, Becky Nagy, Whijae Roh, Brian Chirn, Brittany A. Reeves, Giuliana Malvarosa, Jochen Lennerz, Steven J. Isakoff, Dejan Juric, Douglas Micalizzi, Seth Wander, Laura Spring, Beverly Moy, Kristen Shannon, Jerry Younger, Richard Lanman, Mehmet Toner, A. John Iafrate, Gad Getz, Lee Zou, Leif W. Ellisen, Shyamala Maheswaran, Daniel A. Haber, Aditya Bardia
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (18): 4852–4862.
https://doi.org/10.1158/1078-0432.CCR-20-0638
Published: 15 September 2020
View article titled, Identification of Somatically Acquired <em>BRCA1/2</em> Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer
Open the PDF for Identification of Somatically Acquired <em>BRCA1/2</em> Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses

Tilak K. Sundaresan, Lecia V. Sequist, John V. Heymach, Gregory J. Riely, Pasi A. Jänne, Walter H. Koch, James P. Sullivan, Douglas B. Fox, Robert Maher, Alona Muzikansky, Andrew Webb, Hai T. Tran, Uma Giri, Martin Fleisher, Helena A. Yu, Wen Wei, Bruce E. Johnson, Thomas A. Barber, John R. Walsh, Jeffrey A. Engelman, Shannon L. Stott, Ravi Kapur, Shyamala Maheswaran, Mehmet Toner, Daniel A. Haber
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (5): 1103–1110.
https://doi.org/10.1158/1078-0432.CCR-15-1031
Published: 29 February 2016
View article titled, Detection of T790M, the Acquired Resistance <em>EGFR</em> Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses
Open the PDF for Detection of T790M, the Acquired Resistance <em>EGFR</em> Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses in another window
Includes: Supplementary data
Journal Articles

Abstract IA09: Single cell RNA-sequencing of circulating tumor cells

David T. Miyamoto, Yu Zheng, Ben S. Wittner, Richard J. Lee, Huili Zhu, Katherine T. Broderick, Rushil Desai, Brian W. Brannigan, Kshitij S. Arora, Douglas M. Dahl, Lecia V. Sequist, Matthew R. Smith, Ravi Kapur, Chin-Lee Wu, Toshi Shioda, Sridhar Ramaswamy, David T. Ting, Mehmet Toner, Shyamala Maheswaran, Daniel A. Haber
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (1_Supplement): IA09.
https://doi.org/10.1158/1557-3265.PMSCLINGEN15-IA09
Published: 03 January 2016
View article titled, Abstract IA09: Single cell RNA-sequencing of circulating tumor cells
Journal Articles

Developing Standards for Breakthrough Therapy Designation in Oncology

Sandra J. Horning, Daniel A. Haber, Wendy K.D. Selig, S. Percy Ivy, Samantha A. Roberts, Jeff D. Allen, Ellen V. Sigal, Charles L. Sawyers
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (16): 4297–4304.
https://doi.org/10.1158/1078-0432.CCR-13-0523
Published: 13 August 2013
View article titled, Developing Standards for Breakthrough Therapy Designation in Oncology
Open the PDF for Developing Standards for Breakthrough Therapy Designation in Oncology in another window
Includes: Supplementary data
Journal Articles

A Dose-Ranging Study of Cabozantinib in Men with Castration-Resistant Prostate Cancer and Bone Metastases

Richard J. Lee, Philip J. Saylor, M. Dror Michaelson, S. Michael Rothenberg, Malgorzata E. Smas, David T. Miyamoto, Carol A. Gurski, Wanling Xie, Shyamala Maheswaran, Daniel A. Haber, Jonathan G. Goldin, Matthew R. Smith
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (11): 3088–3094.
https://doi.org/10.1158/1078-0432.CCR-13-0319
Published: 30 May 2013
View article titled, A Dose-Ranging Study of Cabozantinib in Men with Castration-Resistant Prostate Cancer and Bone Metastases
Open the PDF for A Dose-Ranging Study of Cabozantinib in Men with Castration-Resistant Prostate Cancer and Bone Metastases in another window
Journal Articles

Reduced Erlotinib Sensitivity of Epidermal Growth Factor Receptor-Mutant Non–Small Cell Lung Cancer following Cisplatin Exposure: A Cell Culture Model of Second-line Erlotinib Treatment

Tan Min Chin, Margaret P. Quinlan, Anurag Singh, Lecia V. Sequist, Thomas J. Lynch, Daniel A. Haber, Sreenath V. Sharma, Jeffrey Settleman
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (21): 6867–6876.
https://doi.org/10.1158/1078-0432.CCR-08-0093
Published: 03 November 2008
View article titled, Reduced Erlotinib Sensitivity of Epidermal Growth Factor Receptor-Mutant Non–Small Cell Lung Cancer following Cisplatin Exposure: A Cell Culture Model of Second-line Erlotinib Treatment
Open the PDF for Reduced Erlotinib Sensitivity of Epidermal Growth Factor Receptor-Mutant Non–Small Cell Lung Cancer following Cisplatin Exposure: A Cell Culture Model of Second-line Erlotinib Treatment in another window
Journal Articles

Increased Prevalence of EGFR-Mutant Lung Cancer in Women and in East Asian Populations: Analysis of Estrogen-Related Polymorphisms

Daphne W. Bell, Brian W. Brannigan, Keitaro Matsuo, Dianne M. Finkelstein, Raffaella Sordella, Jeff Settleman, Tetsuya Mitsudomi, Daniel A. Haber
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (13): 4079–4084.
https://doi.org/10.1158/1078-0432.CCR-07-5030
Published: 01 July 2008
View article titled, Increased Prevalence of <em>EGFR</em>-Mutant Lung Cancer in Women and in East Asian Populations: Analysis of Estrogen-Related Polymorphisms
Open the PDF for Increased Prevalence of <em>EGFR</em>-Mutant Lung Cancer in Women and in East Asian Populations: Analysis of Estrogen-Related Polymorphisms in another window
Journal Articles

Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort

Ben S. Wittner, Dennis C. Sgroi, Paula D. Ryan, Tako J. Bruinsma, Annuska M. Glas, Anitha Male, Sonika Dahiya, Karleen Habin, Rene Bernards, Daniel A. Haber, Laura J. Van't Veer, Sridhar Ramaswamy
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (10): 2988–2993.
https://doi.org/10.1158/1078-0432.CCR-07-4723
Published: 15 May 2008
View article titled, Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort
Open the PDF for Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort in another window
Includes: Supplementary data
Journal Articles

Epidermal Growth Factor Receptor Mutation Testing in the Care of Lung Cancer Patients

Lecia V. Sequist, Victoria A. Joshi, Pasi A. Jänne, Daphne W. Bell, Panos Fidias, Neal I. Lindeman, David N. Louis, Jeffrey C. Lee, Eugene J. Mark, Janina Longtine, Peter Verlander, Raju Kucherlapati, Matthew Meyerson, Daniel A. Haber, Bruce E. Johnson, Thomas J. Lynch
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4403s–4408s.
https://doi.org/10.1158/1078-0432.CCR-06-0099
Published: 20 July 2006
View article titled, <em>Epidermal Growth Factor Receptor</em> Mutation Testing in the Care of Lung Cancer Patients
Open the PDF for <em>Epidermal Growth Factor Receptor</em> Mutation Testing in the Care of Lung Cancer Patients in another window
Journal Articles

Summary Statement: Novel Agents in the Treatment of Lung Cancer: Advances in Epidermal Growth Factor Receptor-Targeted Agents

Thomas J. Lynch, Alex A. Adjei, Paul A. Bunn, Jr., Tim G. Eisen, Jeffrey Engelman, Glenwood D. Goss, Daniel A. Haber, John V. Heymach, Pasi A. Jänne, Bruce E. Johnson, David H. Johnson, Rogerio C. Lilenbaum, Matthew Meyerson, Alan B. Sandler, Lecia V. Sequist, Jeffrey Settleman, Kwok-Kin Wong, Carol S. Hart
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4365s–4371s.
https://doi.org/10.1158/1078-0432.CCR-06-1005
Published: 20 July 2006
View article titled, Summary Statement: Novel Agents in the Treatment of Lung Cancer: Advances in Epidermal Growth Factor Receptor-Targeted Agents
Open the PDF for Summary Statement: Novel Agents in the Treatment of Lung Cancer: Advances in Epidermal Growth Factor Receptor-Targeted Agents in another window
Journal Articles

Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas

Eunice L. Kwak, Janusz Jankowski, Sarah P. Thayer, Gregory Y. Lauwers, Brian W. Brannigan, Patricia L. Harris, Ross A. Okimoto, Sara M. Haserlat, David R. Driscoll, David Ferry, Beth Muir, Jeff Settleman, Charles S. Fuchs, Matthew H. Kulke, David P. Ryan, Jeff W. Clark, Dennis C. Sgroi, Daniel A. Haber, Daphne W. Bell
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4283–4287.
https://doi.org/10.1158/1078-0432.CCR-06-0189
Published: 20 July 2006
View article titled, Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas
Open the PDF for Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas in another window
Journal Articles

“Oncogenic Shock”: Explaining Oncogene Addiction through Differential Signal Attenuation

Sreenath V. Sharma, Michael A. Fischbach, Daniel A. Haber, Jeffrey Settleman
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4392s–4395s.
https://doi.org/10.1158/1078-0432.CCR-06-0096
Published: 20 July 2006
View article titled, “Oncogenic Shock”: Explaining Oncogene Addiction through Differential Signal Attenuation
Open the PDF for “Oncogenic Shock”: Explaining Oncogene Addiction through Differential Signal Attenuation in another window
Journal Articles

A Blood-Based Test for Epidermal Growth Factor Receptor Mutations in Lung Cancer

Daphne W. Bell, Daniel A. Haber
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (13): 3875–3877.
https://doi.org/10.1158/1078-0432.CCR-06-0670
Published: 03 July 2006
View article titled, A Blood-Based Test for <em>Epidermal Growth Factor Receptor</em> Mutations in Lung Cancer
Open the PDF for A Blood-Based Test for <em>Epidermal Growth Factor Receptor</em> Mutations in Lung Cancer in another window
Journal Articles

Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib

David M. Jackman, Beow Y. Yeap, Lecia V. Sequist, Neal Lindeman, Alison J. Holmes, Victoria A. Joshi, Daphne W. Bell, Mark S. Huberman, Balazs Halmos, Michael S. Rabin, Daniel A. Haber, Thomas J. Lynch, Matthew Meyerson, Bruce E. Johnson, Pasi A. Jänne
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (13): 3908–3914.
https://doi.org/10.1158/1078-0432.CCR-06-0462
Published: 03 July 2006
View article titled, Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib
Open the PDF for Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib in another window
Journal Articles

Response of Some Head and Neck Cancers to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors May Be Linked to Mutation of ERBB2 rather than EGFR

Ezra E.W. Cohen, Mark W. Lingen, Leslie E. Martin, Patricia L. Harris, Brian W. Brannigan, Sara M. Haserlat, Ross A. Okimoto, Dennis C. Sgroi, Sonika Dahiya, Beth Muir, John R. Clark, James W. Rocco, Everett E. Vokes, Daniel A. Haber, Daphne W. Bell
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (22): 8105–8108.
https://doi.org/10.1158/1078-0432.CCR-05-0926
Published: 18 November 2005
View article titled, Response of Some Head and Neck Cancers to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors May Be Linked to Mutation of <em>ERBB2</em> rather than <em>EGFR</em>
Open the PDF for Response of Some Head and Neck Cancers to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors May Be Linked to Mutation of <em>ERBB2</em> rather than <em>EGFR</em> in another window
Journal Articles

Epidermal Growth Factor Receptor Mutations in Non–Small Cell Lung Cancer: Predicting Clinical Response to Kinase Inhibitors

Lecia V. Sequist, Daniel A. Haber, Thomas J. Lynch
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (16): 5668–5670.
https://doi.org/10.1158/1078-0432.CCR-05-1055
Published: 22 August 2005
View article titled, Epidermal Growth Factor Receptor Mutations in Non–Small Cell Lung Cancer: Predicting Clinical Response to Kinase Inhibitors
Open the PDF for Epidermal Growth Factor Receptor Mutations in Non–Small Cell Lung Cancer: Predicting Clinical Response to Kinase Inhibitors in another window